Alejandro Fernandez, MBA, has been named one of the 2016 Power Leaders in Health Care by South Florida Business Journal.
GI & Endoscopy
Takeda Pharmaceutical's Entyvio (vedolizumab) may improve clinical outcomes for patients suffering from ulcerative colitis, according to a study in Clinical Gastroenterology and Hepatology. These improved clinical outcomes were seen irrespective of a patient's treatment history.
The National Committee for Quality Assurance recently published their 2017 Healthcare Effectiveness Data and Information Set quality measures for colorectal cancer screening, which included Exact Sciences' Cologuard.
Miami, FL – October 4th, 2016, Alejandro Fernandez, MBA, CMPE, CEO of Gastro Health, LLC was recently named by South Florida Business Journal as one of the top Power Leaders in Healthcare for 2016.
The first international Endoscopy Ultrasound and ERCP Workshop concluded last weekend, The News reports. Here's are some takeaways from the event.
Advertisement
McAlester (Okla.) Regional Health Center hired gastroenterologist Michael Grossman, MD, to its team, McAlester News-Capital reports.
Long-term use of Takeda Pharmaceutical's Entyvio (vedolizumab) may improve quality of life for patients suffering from inflammatory bowel disease, according to two interim reports published in the Journal of Crohn’s and Colitis.
Cchek early cancer detection technology has successfully been used to identify the presence of liver cancer.
Jose Rodriguez, MD, is providing patients with virtual colonoscopy to screen for colorectal cancer, according to The Monitor.
A team of physicians led by Joanna Aizenberg, MD, created a transparent surface coating for an endoscope that keeps blood and other fluids away, R&D Mag reports.